Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
First Claim
1. A method of assessing euchromatin, comprising:
- preferentially staining euchromatin in biological cells;
measuring at least one variable, said at least one variable comprising at least one of an amount of said euchromatin and a distribution of said euchromatin; and
comparing said at least one variable to a reference value, wherein the reference value represents at least one of a known amount of euchromatin and a known distribution of euchromatin in reference cells.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention is a method of identifying and assessing DNA euchromatin in biological cells. The amount and/or distribution of DNA euchromatin generally relates to RNA/protein synthesis, which may change in certain conditions, such as disease, and/or cellular response to environmental and/or chemical agents. The present invention detects the potential presence of disease by assessing DNA euchromatin in ostensibly normal cells and similarly provides means to monitor and assess treatment response. The present invention may also be used to assess how application (or removal) of influences, such as environment, radiation, chemical agents, medications, herbs, vitamins, etc., interact to effect cells, establishing uses in monitoring wellness and pharmacological screening. Additional uses include assessing age related disorders, allergies, infections, Alzheimer'"'"'s disease, ‘Time of Death’, chronic fatigue syndrome, etc. The method may be advantageously applied to biological cells including micro-organisms, plants, animals, or cultured cells, alone or in conjunction with other markers.
33 Citations
44 Claims
-
1. A method of assessing euchromatin, comprising:
-
preferentially staining euchromatin in biological cells; measuring at least one variable, said at least one variable comprising at least one of an amount of said euchromatin and a distribution of said euchromatin; and comparing said at least one variable to a reference value, wherein the reference value represents at least one of a known amount of euchromatin and a known distribution of euchromatin in reference cells. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
-
21. A method of assessing euchromatin in biological cells, comprising:
- preferentially staining euchromatin in a first set of biological cells taken from an organism;
measuring at least one variable, said at least one variable comprising at least one of an amount of said euchromatin and a distribution of said euchromatin in said first set of biological cells; expressing at least one of said measured amount and said measured distributior in said first set of biological cells as a basal cell response factor relating to said euchromatin;
altering an influence on the organism;preferentially staining euchromatin in a second set of biological cells taken from the organism after said altering step; measuring at least one variable, said at least one variable comprising at least one of an amount of said euchromatin and a distribution of said euchromatin in said second set of biological cells; expressing at least one of said measured amount and said measured distribution in said second set of biological cells as an exposure cell response factor relating to said euchromatin; and comparing said basal cell response factor to said exposure cell response factor. - View Dependent Claims (22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)
- preferentially staining euchromatin in a first set of biological cells taken from an organism;
Specification